Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
批准号:
302201
负责人:
O'Brien Catherine A
金额:
$21.86万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-12-01 至 2018-12-01
中文摘要
结直肠癌(CRC)是加拿大癌症死亡的第二大原因,每年有9200人死亡。我们以前已经证明,癌基因是由结直肠癌起始细胞(CC-IC)的一个子集启动和维持的。还在不断增加
英文摘要
Colorectal cancer (CRC) is the 2nd leading cause of cancer mortality in Canada, with 9,200 deaths annually. We have previously shown that CRCs are initiated and maintained by a subset of colorectal cancer-initiating cells (CC-ICs). There is also increasin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of CBP/p300 bromodomain activity increases chemosensitivity of p53 mutant colorectal cancers through inhibiting p53 aggregation
-
批准号:472399
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:O'Brien Catherine A
-
依托单位:
Molecular drivers of the drug tolerant persister state in patient-derived colorectal cancer models
-
批准号:434963
-
项目类别:Operating Grants
-
资助金额:$69.94万
-
财政年份:2020
-
负责人:O'Brien Catherine A
-
依托单位:
Canada Research Chair - Tier 2
-
批准号:415401
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2019
-
负责人:O'Brien Catherine A
-
依托单位:
Colorectal cancer stem cell plasticity: A novel therapeutic target
-
批准号:334266
-
项目类别:Operating Grants
-
资助金额:$88.93万
-
财政年份:2015
-
负责人:O'Brien Catherine A
-
依托单位:
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal
-
批准号:281581
-
项目类别:Operating Grants
-
资助金额:$45.58万
-
财政年份:2013
-
负责人:O'Brien Catherine A
-
依托单位: